Clinical Trial Update: FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments [NA]

View source ↗

Summary

Clinical trial update describing completion of a study evaluating a FHIR-enhanced RealRisks tool to improve accuracy of breast cancer risk assessments.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Columbia University | Conditions: Breast Cancer | NA | Status: COMPLETED